Tag : Novavax

Latest News

Novavax starts Phase III Covid-19 vaccine trial in U.K.

Newsemia
The company, which also published Phase I data from its Phase I/II study earlier this month, is enrolling 10,000 volunteers aged 18 to 84 for...
Latest News

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

Newsemia
NVX-CoV2373, a recombinant nanoparticle vaccine developed by Novavax and manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic – inducing T-cell response...
Latest News

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Newsemia
A new study by researchers from the Scripps Research Institute and Novavax Inc. in the US affirms the structural integrity of the full-length SARS-CoV-2 spike...
Latest News

Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) – Featuring Medicago, Moderna & Novavax Among Others – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025” report...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World